NCT02347046View on ClinicalTrials.gov

Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Renal InsufficiencyHealthy
Interventions
DRUG

FYU-981, (Oral single dosing)

FYU-981, (Oral single dosing)

Trial Locations (1)

Unknown

Japan, Kagoshima

Sponsors
All Listed Sponsors
lead

Fuji Yakuhin Co., Ltd.

INDUSTRY